Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 551
- 试验地点
- 1
- 主要终点
- Site costs of administering IV iron to subjects to be assessed by applying unit costs to information collected directly on the eCRF (electronic Case Report Form).
研究概览
简要总结
The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
详细描述
The primary objective of this study is to compare the total costs to sites and payers of administering IV iron over the 30-day observation period for subjects with IDA who receive Ferric Carboxymaltose (FCM) relative to those who receive iron sucrose, iron dextran, and ferumoxytol.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must present for the first dose of a current cycle of IV treatment for IDA
- •Must be over 18 years of age
- •Must be willing and able to provide informed consent, including permission to obtain information from their medical records.
- •Must be able to read and understand English.
排除标准
- •Subjects not diagnosed with IDA.
- •Subjects requiring more than one treatment cycle within 30 days.
- •Subjects receiving maintenance IV iron therapy.
- •Subjects treated with IV iron within the 30-day period prior to study enrollment.
- •Subjects who received investigational medication in the six months prior to the study.
结局指标
主要结局
Site costs of administering IV iron to subjects to be assessed by applying unit costs to information collected directly on the eCRF (electronic Case Report Form).
时间窗: 30 day observation period
次要结局
未报告次要终点